Edwards Lifesciences has received the US Food and Drug Administration (FDA) approval for its SAPIEN M3 mitral valve replacement system.

Metal valve covers can last longer, but modern cars use plastic because they're cheaper and lightweight, reducing cost and ...

Maintaining valves throughout a plant’s lifetime helps to preserve optimal performance, minimize supply disruptions and ...

TAVR replaces the damaged aortic valve without the need for open-heart surgery. In this procedure, doctors insert a thin, ...

Regional variations in market growth reflect differences in healthcare infrastructure and adoption rates, with North America and Asia-Pacific leading the way. Companies operating in the market ...

Irvine, California Friday, December 26, 2025, 11:00 Hrs [IST] ...

Structural heart news arrived in a steady stream throughout 2025—from pivotal trials to approvals, reimbursement decisions, ...

General Motors has filed a new patent that offers a look at how the company may be rethinking cylinder deactivation for its ...

A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.

Edwards Lifesciences stock is supported by its growth outlook and the impact of clinical advances. See why investors should ...